Skip to main content
. 2021 Aug 17;16(8):e0256083. doi: 10.1371/journal.pone.0256083

Fig 2.

Fig 2

(A) The prevalence of MS in subjects with obesity, visceral adiposity, or sarcopenia was higher than that in subjects without these parameters (P < 0.001 for all). (B) The prevalence of severe MS in subjects with obesity, visceral adiposity, or sarcopenia was higher than that in subjects without them (P < 0.001 for all). MS, metabolic syndrome.